Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
Public ClinicalTrials.gov record NCT02429258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02429258
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Interventions
- Farxiga Drug
- Placebo Drug
- Metformin Drug
- Insulin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Sep 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- Jun 13, 2017
2015
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Huntington Park | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | West Hills | California | — | — |
| Research Site | Cooper City | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Evanston | Illinois | — | — |
| Research Site | Oxon Hill | Maryland | — | — |
| Research Site | Henderson | Nebraska | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Greensboro | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dublin | Ohio | — | — |
| Research Site | Franklin | Ohio | — | — |
| Research Site | Eugene | Oregon | — | — |
| Research Site | Lansdale | Pennsylvania | — | — |
| Research Site | Spartanburg | South Carolina | — | — |
| Research Site | Bartlett | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Hurst | Texas | — | — |
| Research Site | Renton | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02429258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02429258 live on ClinicalTrials.gov.